SCHEMBL94449

SCHEMBL94449

[CH2]C(CC)c1cccs1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL145744 0.80 GLA (0.39)
SCHEMBL8653457 0.79 GLA (0.35)
SCHEMBL7467588 0.77 HDAC1 (0.37)
SCHEMBL2880798 0.77 ALOX5 (0.39)
SCHEMBL8802037 0.76 ALOX5 (0.33)
SCHEMBL94688 0.76
SCHEMBL12311962 0.76
SCHEMBL8360059 0.75 CES2 (0.34)
SCHEMBL324034 0.75 CYP2C19 (0.48)
SCHEMBL94536 0.75

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100137440-A1 LYSINE RIBOSWITCHES, STRUCTURE-BASED COMPOUND DESIGN WITH LYSINE RIBOSWITCHES, AND METHODS AND COMPOSITIONS FOR USE OF AND WITH LYSINE RIBOSWITCHES YALE UNIVERSITY (US) 2010-06-03 US claimed
EP-2061799-A2 METHODS AND COMPOSITIONS FOR THE USE OF LYSINE RIBOSWITCHES YALE UNIVERSITY (US) 2009-05-27 EP claimed
WO-2008033866-A2 METHODS AND COMPOSITIONS FOR THE USE OF LYSINE RIBOSWITCHES YALE UNIVERSITY (US) 2008-03-20 WO claimed
EP-0457773-A4 N?6 -SUBSTITUTED 9-METHYLADENINES: A NEW CLASS OF ADENOSINE RECEPTOR ANTAGONISTS 1993-03-10 EP claimed
EP-0457773-A1 N?6 -SUBSTITUTED 9-METHYLADENINES: A NEW CLASS OF ADENOSINE RECEPTOR ANTAGONISTS WHITBY RESEARCH, Inc. (US) 1991-11-27 EP claimed
WO-1990009178-A1 N6-SUBSTITUTED 9-METHYLADENINES: A NEW CLASS OF ADENOSINE RECEPTOR ANTAGONISTS WHITBY RESEARCH, INC. (US) 1990-08-23 WO claimed
US-20130012527-A1 PREQ1 RIBOSWITCHES AND METHODS AND COMPOSITIONS FOR USE OF AND WITH PREQ1 RIBOSWITCHES YALE UNIVERSITY (US) 2013-01-10 US disclosed
EP-2426219-A1 Riboswitches and methods and compositions for use of and with riboswitches Yale University (US) 2012-03-07 EP disclosed
EP-2426218-A1 Riboswitches and methods and compositions for use of and with riboswitches Yale University (US) 2012-03-07 EP disclosed
US-20100286082-A1 RIBOSWITCHES AND METHODS AND COMPOSITIONS FOR USE OF AND WITH RIBOSWITCHES YALE UNIVERSITY (US) 2010-11-11 US disclosed
US-20100152212-A1 PREQ1 RIBOSWITCHES AND METHODS AND COMPOSITIONS FOR USE OF AND WITH PREQ1 RIBOSWITCHES YALE UNIVERSITY (US) 2010-06-17 US disclosed
US-20100137440-A1 LYSINE RIBOSWITCHES, STRUCTURE-BASED COMPOUND DESIGN WITH LYSINE RIBOSWITCHES, AND METHODS AND COMPOSITIONS FOR USE OF AND WITH LYSINE RIBOSWITCHES YALE UNIVERSITY (US) 2010-06-03 US disclosed
EP-2164996-A2 RIBOSWITCHES AND METHODS AND COMPOSITIONS FOR USE OF AND WITH RIBOSWITCHES YALE UNIVERSITY (US) 2010-03-24 EP disclosed
EP-0244803-B1 Novel dopamine beta hydroxylase inhibitors MERRELL DOW PHARMA (US) 1994-10-26 EP disclosed
WO-1994019335-A1 THIAZOLE OR IMIDAZOLE DERIVATIVES AS MAILLARD REACTION INHIBITORS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1994-09-01 WO disclosed
WO-1993022280-A1 SUBSTITUTED CYCLOHEXENE-1,2-BICARBOXYLIC ACID DERIVATIVES AND RAW MATERIALS FOR PRODUCING THEM BASF AKTIENGESELLSCHAFT (DE) 1993-11-11 WO disclosed
EP-0244803-A2 Novel dopamine beta hydroxylase inhibitors MERRELL DOW PHARMACEUTICALS INC. (US) 1987-11-11 EP disclosed
US-4569942-A N,3-Disubstituted 2-oxindole-1-carboxamides as analgesic and antiinflammatory agents PFIZER INC. (US) 1986-02-11 US disclosed
US-4053478-A ARTERIOSCLEROSIS, THROMBOSIS, HYPERTENSION YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JA) 1977-10-11 US disclosed
US-4012412-A USEFUL IN THE TREATMENT OF HYPERTENSION, ARTERIOSCLEROSIS, AND THROMBOSIS YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JA) 1977-03-15 US disclosed